- Giovanna Graziadei1,
- Chiara Refaldi1,
- Wilma Barcellini2,
- Claudia Cesaretti3,
- Elena Cassinero1,
- Khaled M. Musallam4 and
- Maria Domenica Cappellini1⇓
- 1Hereditary Anemia Center, Department of Internal Medicine, Fondazione IRCCS “Ca’ Granda” Ospedale Maggiore Policlinico, Università di Milano, Milano, Italy
- 2Hematology Unit, Fondazione IRCCS “Ca’ Granda” Ospedale Maggiore Policlinico, Università di Milano, Milano, Italy
- 3UOSD Genetica Medica, Fondazione IRCCS “Ca’ Granda” Ospedale Maggiore Policlinico, Milano, Italy
- 4Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon
- Correspondence: Maria Domenica Cappellini, M.D., Department of Internal Medicine, Fondazione IRCSS “Ca’ Granda” Ospedale Maggiore Policlinico, Università di Milano, Pad. Granelli, Via Francesco Sforza, 35 20122 Milano, Italy. Phone: international +39.02.55033752. Fax: international +39.02.50320296. E-mail:
β thalassemia intermedia (TI) is a clinical definition referring to a heterogeneous group of hereditary anemias resulting from defective β chain production, an α/β globin chain imbalance, and anemia that lie in severity between that of thalassemia minor and the transfusion-dependent thalassemia major (TM).1 The phenotype of TI may also result from the increased production of α globin chains by a triplicated or quadruplicated α genotype associated with β heterozygosity, also leading to α/β globin chain imbalance, and a presumably mild clinical phenotype.2–5 We report here 2 siblings with transfusion-independent TI who had immediate worsening of their clinical course and became transfusion-dependent after splenectomy, and discuss how the absolute excess of α globin chains in these 2 patients may explain this development.
The father was diagnosed with TI at the age of 16 years (baseline hemoglobin level 80–85 g/L) and the mother had a normal hematologic profile. The 2 parents are not consanguineous at least as far back as four generations, although both are from a small village in the North East of Italy. The 2 children were diagnosed with TI at the ages of two and four years. The 2 children, who had never been transfused before (baseline hemoglobin levels 75–80 g/L), underwent splenectomy at the ages of ten and 12 years because of splenomegaly and secondary anemia. Five months following splenectomy, the clinical course of both patients worsened and anemia (hemoglobin level <70 g/L) necessitated initiating a transfusion regimen. Chelation therapy was initiated at the ages of 14 and 19 years. The younger child had thrombophlebitis at 17 years. The father, now aged 51 years, shows a well tolerated chronic hemolytic anemia without the need for transfusion (hemoglobin level maintained at 80–85 g/L), mild jaundice, splenomegaly and leg ulcers. The mother, still has a completely normal hematological profile and hemoglobin pattern.
The father and the 2 children were initially considered to have unusual TI because at molecular analysis they were carriers of a single β+ mutation (IVS1-110 G>A). After the unusual clinical outcome following splenectomy, all family members were referred to our center for molecular reevaluation. As according to our center’s ethical committee guidelines, all family members signed written informed consent to molecular studies for both diagnostic and research purposes. DNA analysis of β and α globin genes was performed. Mutation analysis of the β globin gene was established by direct DNA sequencing on the ABI Prism 310 genetic analyzer (PE Biosystems Foster City CA, USA). The α globin gene cluster was analyzed by Multiplex Ligation-dependent Probe Amplification (MLPA) according to Harteveld et al.4,6 RNA analysis was performed in triplicate on TaqMan 7500 (PE Biosystems Foster City, CA, USA) after DNAse treatment using specific gene assay (HBA1/2: Hs00361191_g1). The relative quantification (RQ) of alpha genes expression was achieved by normalization against two different house-keeping genes Beta-actine (ACTB:Hs99999903_m) and β2 microglobuline (β2M:Hs00187842-m1) using the 2−ΔΔct formula.
Molecular analysis confirmed that the father and the 2 children were heterozygotes for the β+ mutation IVSI-110 G>A. MLPA analysis disclosed a full duplication of the α globin locus spanning at least 175 kb, from the telomere to the 3’HVR downstream of the α globin gene, including the upstream regulatory element HS-40 (Figure 1A).4 This rearrangement increases the number of functional α globin genes in cis from 2 to 4 and was found in heterozygosis in both parents and in homozygosis in both children. The overproduction of alpha chains was confirmed by Q-PCR experiments with RQ increased in all members of the family (Figure 1B). As expected, the parents showed RQ values of about 1.5 while the children showed values of about 2. Hematologic and molecular data of the family are summarized in Table 1.
In the father, coinheritance of a β globin mutation with 6 α globin genes led to a moderate-severe, well tolerated TI phenotype. The 2 children had 8 functional α globin genes (since the regulatory element HS-40 was also duplicated) producing a large amount of α chains (twice than normal) that, associated with reduced β chain production, causes a severe α/β globin imbalance.
In transfusion-independent TI, erythropoietic stress, ineffective erythropoiesis, and chronic intravascular hemolysis are highly variable. An increased number of erythroblasts, reticulocytes, and damaged erythrocytes are seen in the peripheral blood. The excess free α chains precipitate within the erythroid precursors, form hemi-chromes, and alter the membrane cytoskeletal proteins by clustering band 3 and enhancing deposition of opsonin autologous immunogobulins and C3 fragments.7–8 About 80% of senescent or altered erythrocytes are removed extravascularly by macrophages present mainly in the spleen.7 Thus, removal of the spleen in patients with an absolute excess of α chains, as in our patients, may lead to more severe hemolysis and persistence of damaged erythroblasts and erythrocytes in the blood stream compared to patients with defective β chain production and a relative excess of α chains. These persistent abnormal erythroid cells may justify the high rate of thromboembolism in splenectomized TI patients,9–10 including the one reported herein. They acquire procoagulant properties from increased exposure of phosphatidylserine instead of phosphatidyletanolamine on their outer surface, by an altered flip flop mechanism mediated by band 3 clusters.11 Thus, in the 2 siblings, splenectomy was associated with an increase in the number of nucleated red blood cells (as documented in the blood smear), increased peripheral hemolysis (worsening anemia), and increased risk of thrombotic events (in one of the children).
In the light of several reports linking splenectomy to adverse long-term outcomes, it was recently recommended that the decision to perform a splenectomy in TI patients should be taken with caution and the procedure should be avoided or delayed unless absolutely necessary.1 Given our experience, we agree with this recommendation, especially in TI patients characterized by a severe imbalance between α/non-α globin chains due to an absolute excess of α globin chains. We also recommend including α globin gene testing in the molecular workup of patients with TI where the β gene defect does not completely explain the observed phenotype.
- Copyright© Ferrata Storti Foundation